Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating multiple sclerosis.

Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment ...

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

New research suggests that multiple sclerosis may begin influencing patients’ health far earlier than previously recognized. Multiple sclerosis (MS) is often recognized only after unmistakable ...

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...

BERLIN, Feb 7 (Reuters) - Swiss pharmaceutical company Roche said on Saturday its experimental multiple sclerosis drug fenebrutinib met the main goal in a late-stage trial in patients with primary ...

Cognitive health is not only the absence of cognitive impairment. It's the ability to maintain mental efficiency, flexibility, and emotional balance despite the burden of the disease. Cognitive ...

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New research from Sweden links higher levels of per- and polyfluoroalkyl ...

The Multiple Sclerosis Society of Bermuda today announced its plans for its 2026 Medical Symposium. A spokesperson said, “On Saturday, March 7th, 2026, the Society will hold its next Medical Symposium ...